Griniatsos John, Yiannakopoulou Eugenia, Tsechpenakis Anastasios, Tsigris Christos, Diamantis Theodoros
First Department of Surgery, University of Athens, Medical School, LAIKO Hospital, Athens, Greece.
Surg Laparosc Endosc Percutan Tech. 2009 Oct;19(5):e177-80. doi: 10.1097/SLE.0b013e3181bb859c.
The aim of this technical report is to investigate the safety and effectiveness of a hybrid technique for recurrent incisional hernia repair, which combines the conventional and laparoscopic approaches.
Six patients suffering from recurrent and complicated incisional hernias underwent a hybrid technique for their repair. The open part of the operation ensured extensive and safe adhesiolysis, reduction of the hernia content into the peritoneal cavity, and proper placement of the bowel loops into the peritoneal cavity, minimizing the risk of bowel perforation. For the laparoscopic part of the procedure, intraperitoneal (underlay) e-PTFE mesh placement, of the appropriate size covering the actual hernia size and the scar edges for at least 3 cm, was laparoscopically fixated by transfascial stay stitches, allowing stretch of the mesh on the anterior abdominal wall, probably avoiding the mesh deformation in the future.
The overall size of the fascial defect was calculated between 116 and 187 cm, the size of the mesh used ranged from 308 to 468 cm, the total operative time ranged from 128 to 207 minutes and within a maximum follow-up period of 12 months, all patients are asymptomatic without any evidence of hernia recurrence.
The hybrid technique is safe in cases of recurrent or complicated or difficult incisional hernias. A longer follow-up period is required to estimating the effectiveness and the cost-effectiveness of the method.
本技术报告旨在研究一种用于复发性切口疝修补的混合技术的安全性和有效性,该技术结合了传统方法和腹腔镜方法。
6例患有复发性复杂性切口疝的患者接受了混合技术修补。手术的开放部分确保了广泛且安全的粘连松解、将疝内容物回纳入腹腔以及将肠袢妥善放置于腹腔内,从而将肠穿孔风险降至最低。对于手术的腹腔镜部分,通过经筋膜缝扎线将适当尺寸(覆盖实际疝大小及瘢痕边缘至少3厘米)的腹膜内(衬于腹膜下)e-PTFE补片进行腹腔镜固定,使补片能在前腹壁伸展,可能避免补片在未来发生变形。
筋膜缺损的总体大小经计算在116至187平方厘米之间,所用补片大小在308至468平方厘米之间,总手术时间在128至207分钟之间,并且在最长12个月的随访期内,所有患者均无症状,无任何疝复发迹象。
混合技术在复发性、复杂性或困难性切口疝病例中是安全的。需要更长的随访期来评估该方法的有效性和成本效益。